Clinical and Molecular Hepatology

"Mary Yue Wang"

Editorial

Spotting undiagnosed significant liver fibrosis in the general population: impact on subsequent clinical care: Editorial on “Prevalence of clinically significant liver fibrosis in the general population: A systematic review and meta-analysis”: Nana Peng, Mary Yue Wang, Sherlot Juan Song, Terry Cheuk-Fung Yip; Clin Mol Hepatol 2025;31(1):256-260.
Published online September 3, 2024; DOI: https://doi.org/10.3350/cmh.2024.0737

Citations

Citations to this article as recorded by

Interest of biochemical monitoring of liver function for patients under anti-tuberculosis treatment
Alsayed Ahmad Dana, Chikhi Aicha, Sai Touba, Benzitouni Aicha, Aoues Khadidja, Khelfi Abderrezak
Drug and Chemical Toxicology.2026; : 1. CrossRef
Immune escape mechanisms revealed by multifunctional nanoprobes targeting PD‐L1 in hepatic cancer progression
Yiteng Meng, Liwen Jing, Yeda Chen, Shenggang Zhan, Feng Xiong, Wenbiao Chen
VIEW.2026;[Epub] CrossRef
Enzyme‐responsive 612‐AYR nanoparticles for targeted inhibition of B4GALT3‐mediated ITGB1 glycosylation in hepatocellular carcinoma
Xiaohui Yu, Xiaoyan Chen, Hui Guo, Xia Jin, Pingping Tan, Longwu Zeng, Yan He, Junjun Li
British Journal of Pharmacology.2026; 183(16): 4989. CrossRef
Correspondence to editorial on “Prevalence of clinically significant liver fibrosis in the general population: A systematic review and meta-analysis”
Hee Yeon Kim, Miyoung Choi, Dae Won Jun
Clinical and Molecular Hepatology.2025; 31(1): e48. CrossRef